Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)
Andreas Glenthoej(Copenhagen University Hospital), Kevin H.M. Kuo(University Health Network), Fatiha Chermat(Groupe Francophone des Myélodysplasies), Niels Vejlstrup(Copenhagen University Hospital), Minke A.E. Rab(Utrecht University), Jesper Petersen(Copenhagen University Hospital), Richard van Wijk(Utrecht University), Jens Helby(University of Copenhagen), Selma Kofoed Bendtsen(Copenhagen University Hospital), Nina Toft(Copenhagen University Hospital), Eduard J. van Beers(Utrecht University), Evelyn Groot(University Medical Center Utrecht), Pierre Fenaux(Saint Louis University Hospital)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k